3,4-dihydroxyphenylacetic acid has been researched along with perindopril in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Araki, T; Imai, Y; Itoyama, Y; Kato, H; Kurosaki, R; Muramatsu, Y; Watanabe, Y | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylacetic acid and perindopril
Article | Year |
---|---|
Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Count; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Electrochemistry; Homovanillic Acid; Immunohistochemistry; Interneurons; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Parvalbumins; Perindopril; Time Factors; Tyrosine 3-Monooxygenase | 2005 |